Factor analysis of treatment acceptability in double-blind randomised clinical trial of home-based transcranial direct current stimulation in major depression and in healthy individuals.

Saved in:
Bibliographic Details
Title: Factor analysis of treatment acceptability in double-blind randomised clinical trial of home-based transcranial direct current stimulation in major depression and in healthy individuals.
Authors: Lagerberg PJ; Department of Psychology, University of East London, UK., Xue L; Centre for Affective Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK., Woodham RD; Department of Psychology, University of East London, UK., Selvaraj S; Center of Excellence on Mood Disorders, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center at Houston, TX, USA.; Intra-Cellular Therapies, Inc., New York, NY, USA., Lajmi N; Department of Psychology, University of East London, UK., Hobday H; Department of Psychology, University of East London, UK., Sheehan G; Department of Psychology, University of East London, UK., Ghazi-Noori AR; Department of Psychology, University of East London, UK., Rizvi M; Center of Excellence on Mood Disorders, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center at Houston, TX, USA., Kwon SS; Center of Excellence on Mood Disorders, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center at Houston, TX, USA., Orhii P; Center of Excellence on Mood Disorders, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center at Houston, TX, USA., Chapman S; Department of Psychology, University of East London, UK., de Jesus da Silva A; Department of Psychology, University of East London, UK., Hanifa E; Department of Psychology, University of East London, UK., Morety S; Department of Psychology, University of East London, UK., Oxbury P; Department of Psychology, University of East London, UK., Machado-Vieira R; Center of Excellence on Mood Disorders, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center at Houston, TX, USA., Soares JC; Center of Excellence on Mood Disorders, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center at Houston, TX, USA., Young AH; Centre for Affective Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.; National Institute for Health Research Biomedical Research Centre at South London and Maudsley NHS Foundation Trust, King's College London, UK.; South London and Maudsley NHS Foundation Trust, Bethlem Royal Hospital, Beckenham, UK.; Department of Psychiatry, Imperial College London, UK., Fu CHY; Department of Psychology, University of East London, UK.; Centre for Affective Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.; South London and Maudsley NHS Foundation Trust, Bethlem Royal Hospital, Beckenham, UK.
Source: Journal of psychopharmacology (Oxford, England) [J Psychopharmacol] 2026 Apr; Vol. 40 (4), pp. 586-594. Date of Electronic Publication: 2025 Dec 26.
Publication Type: Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Sage Publications Country of Publication: United States NLM ID: 8907828 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1461-7285 (Electronic) Linking ISSN: 02698811 NLM ISO Abbreviation: J Psychopharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1461-7285
DOI:10.1177/02698811251399545